|
MAD2L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8940799999978E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.657600E-02 |
| Normal-vs-Stage2 |
5.881700E-02 |
| Normal-vs-Stage3 |
4.23689999999866E-05 |
| Normal-vs-Stage4 |
1.431650E-02 |
| Stage1-vs-Stage2 |
1.334600E-01 |
| Stage1-vs-Stage3 |
2.998100E-04 |
| Stage1-vs-Stage4 |
2.361600E-02 |
| Stage2-vs-Stage3 |
3.368600E-01 |
| Stage2-vs-Stage4 |
1.708590E-01 |
| Stage3-vs-Stage4 |
3.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.80780000000169E-05 |
| Normal-vs-AfricanAmerican |
2.710000E-02 |
| Normal-vs-Asian |
6.822200E-02 |
| Caucasian-vs-AfricanAmerican |
6.777600E-01 |
| Caucasian-vs-Asian |
2.625000E-01 |
| AfricanAmerican-vs-Asian |
2.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.779600E-03 |
| Normal-vs-Female |
2.18190000000895E-06 |
| Male-vs-Female |
1.121950E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.583700E-03 |
| Normal-vs-Extreme_Weight |
1.119830E-01 |
| Normal-vs-Obese |
9.844900E-04 |
| Normal-vs-Extreme_Obese |
7.359600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.648400E-02 |
| Normal_Weight-vs-Obese |
9.409800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.379800E-03 |
| Extreme_Weight-vs-Obese |
1.442140E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.016200E-01 |
| Obese-vs-Extreme_Obese |
3.820500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.425930E-02 |
| Normal-vs-Age(41-60Yrs) |
2.579900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.256700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.997800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.832400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.489900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.044000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.621800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.088600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.986600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.697820E-01 |
| Normal-VS-Type2 PRCC |
5.92200000000265E-05 |
| Normal-VS-KIRP CIMP |
7.209500E-04 |
| Normal-VS-Unclassified PRCC |
4.142000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.040600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.402200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.962180E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.262300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.656800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.217400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.981770E-02 |
| Normal-vs-N1 |
2.65550000000392E-06 |
| Normal-vs-N2 |
1.176150E-01 |
| N0-vs-N1 |
1.391470E-04 |
| N0-vs-N2 |
1.821980E-02 |
| N1-vs-N2 |
8.597600E-01 |
|
|
